The FDA has approved Colcrys (colchicine tablets, from AR Scientific), a single-ingredient oral colchicine product, for the treatment of familial Mediterranean fever (FMF) in patients ≥4 years of age ...

Analysis of Pivotal AGREE Trial Finds No Correlation Between Incidence of Adverse Events and Age, Disease Duration or Gout-Related Comorbidities ATLANTA, Nov. 8, 2010 /PRNewswire/ -- Patients who ...

Please provide your email address to receive an email when new articles are posted on . The approval of Colcrys in July 2009 and its market exclusivity that followed created higher costs and reduced ...

A so-called authorized generic version of the colchicine formulation sold as Colcrys for acute gout flares and for treating familial Mediterranean fever will be "widely available" starting later this ...

Colcrys, a new colchicine formulation, has received marketing clearance for the prevention of gout flares. The FDA first approved the oral medication in July for the treatment of acute gout flares ...

The prescription rate of Colcrys for the treatment of gout and familial Mediterranean fever has significantly decreased following the FDA order granting Colcrys market exclusivity, according to a ...

Doris Webb was diagnosed last year with a rare disease called familial Mediterranean fever. It’s a hereditary condition tied to her French ancestry, causing recurrent fevers, arthritis attacks and ...

URL Pharma Inc. is getting a new owner. Takeda America Holdings Inc. agreed Wednesday to buy the privately owned Philadelphia branded and generic drug manufacturer for $800 million up front plus ...

Public spending on colchicine has grown exponentially over the past decade despite generics suggesting an uphill slog for patients seeking access to long-term therapy for gout or cardiac conditions.

Takeda suffered a defeat in its battle to keep a competitor to its version of an ancient gout drug off the market. A federal court backed Hikma's right to sell a med with the same active ingredient as ...

AR Scientific has launched Colcrys (colchicine tablets) for the treatment of acute gout flares when taken at the first sign of a flare. Colcrys is also indicated for the treatment of familial ...

Aug. 1 -- FRIDAY, July 31 (HealthDay News) -- Colcrys has been approved by the U.S. Food and Drug Administration to treat acute gout and familial Mediterranean fever (FMF), two inflammatory disorders.